The meeting, which helps the FDA give guidance to vaccine makers on which flu strains to target, is the second to be ...

Verve offered few details on the early end of a collaboration the companies inked in 2022, saying only that Vertex cited “changing priorities.” ...

Woven Health Collective elevates clients’ science, engages the right stakeholders, and magnifies success with a harmonized and highly specialized approach across key areas. All services are backed by ...

While announcing billions of dollars in new U.S. investments, company chief David Ricks called for an extension of 2017 tax ...

The British drugmaker claimed study success in a first-line setting in breast cancer. Elsewhere, Rezdiffra sales continued to ...

CiteAb, a Sci-Tech company specialising in data collection, announces the launch of CiteAb Unlimited for pharmaceutical and biotechnology companies. This service provides private access to a database ...

The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry ...

If you have concerns about your use of Depo-Provera, we would like to hear from you. Please complete the contact form on this page, send us an email at [email protected], or give us a call at (202) ...

The funding comes as Eikon, run by former Merck research chief Roger Perlmutter, has started a Phase 3 trial testing one of ...

Telehealth provider Hims & Hers said it will tell consumers they need to seek “alternative options on the commercial dosing,” ...

Ten of 11 children born with a rare form of congenital hearing loss experienced improvements after receiving the company’s ...

An industry source said “most, if not all” of the people at CDRH who were recently dismissed are now being asked to return.